Chief Medical Officer and Senior Vice President, Research and Development · Traws Pharma, Inc. (TRAW)

Richard Woodman

A named executive officer of Traws Pharma in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$551,525

Salary $393,750Stock awards $55,854Bonus $99,750

FY2019: $425,312

4th of 4 named executive officers at Traws Pharma by FY2020 total.

4 named officers on file for Traws Pharma, FY2020

Richard Woodman’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Traws Pharma’s whole pay program stands against its peers

  • Traws Pharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TRAW→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 28, 2021 (DEF 14A).

Free

Get Richard Woodman’s full pay file as a PDF — free

More than this page: up to 10 years of Richard’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Richard Woodman compensation by year

Traws Pharma Summary Compensation Table · all 2 fiscal years held
In US dollars, as Traws Pharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$375,000$393,750
Bonus$18,740$99,750
Stock awards$0$55,854
Option awards$20,000$0
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$11,572$2,171
Total$425,312$551,525

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Traws Pharma, Inc. DEF 14A filed May 28, 2021, accession 0001104659-21-074323, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Traws Pharma, Inc. filed document, accession 0001104659-21-074323. Every figure is read from that document and cited to the page and table it appears in. Filed May 28, 2021.

$425K
$552K
FY19
FY20
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option639—$87.75
Option3,558—$4.65

Per the Outstanding Equity Awards at Fiscal Year-End table in Traws Pharma, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Traws Pharma’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Manoj ManiarSenior Vice President, Product Development$1,178,491
Steven FruchtmanPresident and Chief Executive Officer$1,031,823
Mark GuerinChief Financial Officer$622,109
Richard Woodman · this pageChief Medical Officer and Senior Vice President, Research and Development$551,525

The full Traws Pharma compensation record

free company brief

This page is one person within Traws Pharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Traws Pharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Richard Woodman's compensation dossier · One-time report. No refunds.